McDermott International (NYSE:MDR) had its underweight rating reiterated by analysts at Morgan Stanley. They currently have a $6.30 target price on the stock, up from their previous target price of $6.00. The analysts wrote, “MDR announced that it is offering 10MM tangible equity units, each with a stated value of $25, with a green shoe option of 1.5MM units. Mc Dermott International (NYSE:MDR) shares after opening at $7.53 moved to $7.61 on last trade day and at the end of the day closed at $7.03. Company price to sales ratio in past twelve months was calculated as -31.20 and price to cash ratio as -16.80. Mc Dermott International (NYSE:MDR) showed a negative weekly performance of -12.34%.
A U.S. Disctrict Court in Delaware ruled that The Medicines Company (NASDAQ: MDCO) failed to prove that Hospira’s generic Angiomax product infringes on its existing patents. The court ruled that Hospira’s Abbreviated New Drug Applications did not meet the “efficient mixing” claim limitation and therefore does not infringe on Medicines Co ‘727 and ‘343 patents. Shares hit new 52 week lows of $23.53 before closing the day at $24.02, up 15.48 percent.
The Medicines Company (NASDAQ:MDCO) shares fell -15.48% in last trading session and ended the day on $24.02. MDCO return on equity ratio is recorded as 2.00% and its return on assets is 1.10%. The Medicines Company (NASDAQ:MDCO) yearly performance is -26.90%.
Paul M. Gilbert, a former director of Derma Sciences Inc (NASDAQ:DSCI), resigned from the board of directors of the Company, effective as of March 21, 2014 (the “Effective Date”). The resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. In consideration for his prior service to the Company, Mr. Gilbert received acceleration of vesting of 7,500 unvested restricted share units and 7,500 stock options as of the Effective Date. Derma Sciences Inc (NASDAQ:DSCI) shares moved down -5.28% in last trading session and was closed at $12.01, while trading in range of $ 11.98 – 13.02. Derma Sciences Inc (NASDAQ:DSCI) year to date (YTD) performance is 11.00%.
Ubic Inc (ADR) (NASDAQ:UBIC) , a leading developer of unique, behavioral informatics-based data-analytics technology and services used in legal discovery (eDiscovery) and digital forensic investigations, announced it has relocated its Nagoya, Japan, branch office to new, larger quarters in the city to accommodate the company’s expanding business functions and future growth. The new branch office is operational now and serves as UBIC’s business base in the Nagoya and Tokai areas of Japan. Ubic Inc (ADR)(NASDAQ:UBIC) weekly performance is -14.23%. On last trading day company shares ended up $6.21. Ubic Inc (ADR) (NASDAQ:UBIC) distance from 50-day simple moving average (SMA50) is 9.97%. Analysts mean target price for the company is $7.25.